Arrowhead Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 87.32 USD | 95,49 USD | 15,01 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 104,273 USD | 7 | 4 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 140.857.021 | 9,53 | 3,39 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Arrowhead Pharmaceuticals Inc
Mitarbeiter 711
Handelsplatz NASDAQ
Ticker Symbol ARWR
IPO Datum 1993-06-16
Adresse 177 East Colorado Boulevard, Pasadena, CA, United States, 91105
Webseite https://arrowheadpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Christopher R. Anzalone Ph.D. | Chairman, CEO & President |
| 2 | Mr. Daniel J. Apel | Chief Financial Officer |
| 3 | Mr. Patrick O'Brien J.D., PharmD | COO & Secretary |
| 4 | Dr. James C. Hamilton M.D., MBA | Chief Medical Officer and Head of R&D |
| 5 | Dr. Mark M. Davis Ph.D. | Founder and Founder & Director of Insert Therapeutics Inc & Calando |
| 6 | Dr. Tao Pei Ph.D. | Chief Scientific Officer |
| 7 | Dr. Vincent Anzalone CFA | Head of Investor Relations & VP |
| 8 | Mr. Howard Lovy | Director of Communications |
| 9 | Dr. Bruce D. Given M.D. | Chief Medical Scientist |
| 10 | Dr. Mark Seefeld | Head of Toxicology & VP |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | venBio Select Advisor LLC | 0,00% | 0,00 Mio. USD |
| 4 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | Fred Alger Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 11 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 12 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 13 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 14 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 15 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 16 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 17 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 18 | HHG PLC | 0,00% | 0,00 Mio. USD |
| 19 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 20 | UBS Asset Mgmt Americas Inc | 0,00% | 0,00 Mio. USD |